ICYMI: Dr. Ted Love explains “why drug pricing controls could impede innovation”
BIOtech Now Brian Newell Risky. Costly. Time consuming. Rewarding. Those few words help describe a biopharmaceutical ecosystem where 90% of all clinical […]
Category: News
Oncologist Warns of IPI’s Potentially Dangerous Implications
BIOtech Now Andrew Segerman Writing for Morning Consult, Dr. Lucy Langer, a clinical oncologist with Compass Oncology in Portland, Oregon, applauds the […]
Peter Pitts Examines the Role of PBMs and their Deceptive Tactics
BIOtech Now Andrew Segerman A piece by Peter J. Pitts, a former FDA Associate Commissioner and President of the Center for Medicine […]
Vaccines Work: the Proof Is in the Data.
BIOtech Now Andrew Segerman At the latest meeting of the Advisory Committee on Immunization Practices (ACIP), more than 80 attendees identified themselves […]
Kentucky Officials Expose PBMs for Gaming the System
BIOtech Now Andrew Segerman While many were watching the drug pricing debate unfold on Capitol Hill, the Kentucky Cabinet for Health and […]
The Empty Promise of “Safe” Drug Importation
BIOtech Now Tom DiLenge For years, BIO has been urging both state and federal policymakers to adopt responsible solutions that would make […]
Two New Infographics Illustrate the Success of the Orphan Drug Act
BIOtech Now Andrew Segerman In recognition of Rare Disease Day, BIO’s Jim Greenwood shared commentary on LinkedIn celebrating the success of the […]
With an Air of Optimism, #BIOCEO19 Concludes
BIOtech Now Theresa Brady Despite considerable pressure directed squarely at biotech innovators from politicians of every stripe, biotech executives remained focused on […]
#BIOCEO19: Navigating Payers’ Expectations for Value-Based Agreements
BIOtech Now Rufael Seyum Value-based agreements are becoming increasingly important in the biopharmaceutical reimbursement space, particularly as new advanced therapeutic modalities and […]
Health Care in Focus as President Trump Addresses the Nation
BIOtech Now Andrew Segerman In his State of the Union address, President Trump described the need to rein in health care costs […]
Meet Kallyope’s Nancy Thornberry, Fireside Chat Speaker at #BIOCEO19
BIOtech Now Theresa Brady Biotech startups come in all shapes, sizes and approaches but have one thing in common: the drive to […]
Meet Synlogic’s Aoife Brennan, Fireside Chat Speaker at #BIOCEO19
BIOtech Now Theresa Brady Dr. Aoife Brennan has always faced challenges head-on. A trained endocrinologist, she could have remained in her native […]
Latest Measles Outbreak is a Crash Course on the Importance of Immunization
BIOtech Now Jim Greenwood It’s hard to miss the news coming from the Pacific Northwest. Every major media outlet is covering the […]
Here’s What You Need to Know as Capitol Hill Talks Prescription Drug Costs
BIOtech Now Andrew Segerman Drug prices will be in the spotlight this week as committees in both the House and Senate are […]
A Helpful Spotlight on the Need for More Health Care Transparency
BIOtech Now Brian Newell This week, the Trump administration addressed a problem confronting a growing number of Americans: surprise medical bills. As […]
Greenwood Shines Spotlight on Insurance Industry Rip-off
BIOtech Now Andrew Segerman Writing for The Hill, BIO’s President and CEO Jim Greenwood shined a spotlight on a shocking Wall Street […]
Using Biotechnology to Tackle Deadly Mosquito-Borne Illnesses
BIOtech Now Josh Falzone Every year, nearly a million deaths are attributed to mosquito-borne illnesses and 500 million people are infected with […]
Despite Administration’s “Sky-High Rhetoric,” Importing Foreign Price Controls Will Harm Innovation and Patient Access
BIOtech Now Andrew Segerman In October of 2018, the Trump Administration outlined a proposal that would import foreign price controls for medicines […]
The Right Way to Address Prescription Drug Costs
BIOtech Now Andrew Segerman Writing for STAT News, BIO’s President and CEO Jim Greenwood teamed up with Bay City Capital’s David Beier […]
BIO Illustrates the Success of the Orphan Drug Act
BIOtech Now Andrew Segerman The numbers might surprise you. Approximately 7,000 rare diseases are known to exist, and approximately 30 new ones […]